Insider Trading History of Kayyem Jon Faiz

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Kayyem Jon Faiz since 2008. This trader's CIK number is 1366268. At the time of last reporting, Kayyem Jon Faiz was the Director of Inhibrx Biosciences, Inc.. (stock ticker symbol INBX). Also see all insider trading activities at Inhibrx Biosciences, Inc..

Note that in the past Kayyem Jon Faiz also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Zonagen Inc (RPRX) by Kayyem Jon Faiz

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 RPRX 45,592 $325,714 0 $0 0 $0

Yearly summary of insider trading at Genmark Diagnostics, Inc. (GNMK) by Kayyem Jon Faiz

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 GNMK 0 $0 148 $759 0 $0
2017 GNMK 0 $0 16,158 $173,329 13,631 $0
2016 GNMK 0 $0 4,215 $30,538 169 $0
2015 GNMK 0 $0 13,041 $141,896 0 $0
2014 GNMK 0 $0 187,814 $2,477,439 0 $0
2013 GNMK 0 $0 26,972 $315,401 0 $0
2012 GNMK 50,000 $210,000 0 $0 0 $0
2011 GNMK 100,000 $425,000 0 $0 0 $0
2010 GNMK 250,000 $1,500,000 0 $0 0 $0

Yearly summary of insider trading at Biodesix Inc (BDSX) by Kayyem Jon Faiz

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 BDSX 0 $0 0 $0 291,666 $0
2022 BDSX 173,913 $199,999 0 $0 0 $0

Yearly summary of insider trading at Inhibrx, Inc. (INBX) by Kayyem Jon Faiz

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 INBX 0 $0 9,500 $239,998 0 $0
2022 INBX 0 $0 28,500 $825,968 0 $0

Yearly summary of insider trading at Inhibrx Biosciences, Inc. (INBX) by Kayyem Jon Faiz

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 INBX 344,335 $5,932,888 0 $0 0 $0


Insider trading activities at 5 companies by Kayyem Jon Faiz:

1. Zonagen Inc (RPRX)

2. Genmark Diagnostics, Inc. (GNMK)

3. Biodesix Inc (BDSX)

4. Inhibrx, Inc. (INBX)

5. Inhibrx Biosciences, Inc. (INBX)

Table 1. Insider trading of Zonagen Inc (RPRX) by Kayyem Jon Faiz

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-10-31 RPRX Buy 11,300 7.76 87,688
2008-10-28 RPRX Buy 9,892 6.87 67,958
2008-10-29 RPRX Buy 24,400 6.97 170,068

Table 2. Insider trading of Genmark Diagnostics, Inc. (GNMK) by Kayyem Jon Faiz

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-02-02 GNMK Sale 148 5.13 759
2017-12-04 GNMK Sale 135 4.70 634
2017-11-20 GNMK Sale 1,269 4.74 6,015
2017-11-02 GNMK Sale 135 7.24 977
2017-09-05 GNMK Sale 133 9.75 1,296
2017-08-21 GNMK Sale 1,277 9.45 12,067
2017-08-02 GNMK Sale 138 10.33 1,425
2017-06-02 GNMK Sale 132 12.89 1,701
2017-05-19 GNMK Sale 1,265 12.89 16,305
2017-05-02 GNMK Sale 133 13.34 1,774
2017-03-07 GNMK Sale 311 12.18 3,787
2017-03-03 GNMK Sale 131 12.29 1,609
2017-02-21 GNMK Sale 5,250 10.08 52,920
2017-02-02 GNMK Sale 131 11.58 1,516
2017-01-19 GNMK Option Ex 13,631 .00 0
2017-01-19 GNMK Sale 5,718 12.47 71,303
2016-12-07 GNMK Sale 313 11.08 3,468
2016-12-02 GNMK Sale 132 11.30 1,491
2016-12-02 GNMK Sale 132 11.30 1,491
2016-12-02 GNMK Sale 132 11.30 1,491
2016-11-02 GNMK Sale 135 10.30 1,390
2016-09-07 GNMK Sale 310 8.69 2,693
2016-09-02 GNMK Sale 133 8.62 1,146
2016-08-02 GNMK Sale 135 9.88 1,333
2016-06-03 GNMK Sale 125 8.53 1,066
2016-06-07 GNMK Sale 310 8.98 2,783
2016-03-07 GNMK Sale 364 5.76 2,096
2016-02-03 GNMK Sale 1,916 4.99 9,560
2016-01-21 GNMK Option Ex 169 .00 0
2016-01-21 GNMK Sale 78 6.80 530
2015-12-08 GNMK Sale 328 7.26 2,381
2015-12-02 GNMK Sale 1,189 7.60 9,036
2015-12-03 GNMK Sale 132 7.71 1,017
2015-09-11 GNMK Sale 269 9.64 2,593
2015-09-04 GNMK Sale 113 9.38 1,059
2015-09-02 GNMK Sale 1,045 9.62 10,052
2015-06-16 GNMK Sale 265 9.15 2,424
2015-06-03 GNMK Sale 937 9.53 8,929
2015-06-04 GNMK Sale 105 9.81 1,030
2015-03-09 GNMK Sale 5,575 12.06 67,234
2015-03-11 GNMK Sale 2,750 11.71 32,202
2015-03-10 GNMK Sale 333 11.83 3,939
2014-12-15 GNMK Sale 325 12.51 4,065
2014-12-04 GNMK Sale 1,320 12.06 15,919
2014-10-31 GNMK Sale 6,000 11.01 66,060
2014-09-12 GNMK Sale 314 9.86 3,096
2014-09-05 GNMK Sale 1,506 10.04 15,120
2014-07-01 GNMK Sale 6,000 13.60 81,600
2014-06-11 GNMK Sale 291 11.64 3,387
2014-06-05 GNMK Sale 255 10.78 2,748
2014-06-03 GNMK Sale 1,228 10.67 13,102
2014-05-28 GNMK Sale 6,000 11.06 66,378
2014-03-11 GNMK Sale 1,220 12.17 14,842
2014-03-04 GNMK Sale 7,095 12.47 88,453
2014-03-05 GNMK Sale 260 12.39 3,221
2014-01-16 GNMK Sale 39,481 14.06 555,102
2014-01-15 GNMK Sale 10,519 14.00 147,266
2014-01-02 GNMK Sale 106,000 13.18 1,397,080
2013-12-04 GNMK Sale 1,765 11.14 19,662
2013-10-01 GNMK Sale 6,000 12.14 72,840
2013-09-03 GNMK Sale 1,545 11.60 17,922
2013-08-20 GNMK Sale 1,310 10.15 13,296
2013-07-01 GNMK Sale 6,000 10.40 62,400
2013-04-01 GNMK Sale 6,000 12.93 77,580
2013-03-14 GNMK Sale 4,352 11.88 51,701
2012-06-26 GNMK Buy 50,000 4.20 210,000
2011-06-22 GNMK Buy 100,000 4.25 425,000
2010-06-03 GNMK Buy 250,000 6.00 1,500,000

Table 3. Insider trading of Biodesix Inc (BDSX) by Kayyem Jon Faiz

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-03-31 BDSX Option Ex 145,833 .00 0
2023-03-31 BDSX Option Ex 145,833 .00 0
2022-11-21 BDSX Buy 173,913 1.15 199,999

Table 4. Insider trading of Inhibrx, Inc. (INBX) by Kayyem Jon Faiz

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-01-23 INBX Sale 9,500 25.26 239,998
2022-12-21 INBX Sale 9,500 27.24 258,761
2022-11-21 INBX Sale 9,500 29.72 282,378
2022-10-21 INBX Sale 9,500 29.98 284,829

Table 5. Insider trading of Inhibrx Biosciences, Inc. (INBX) by Kayyem Jon Faiz

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-06-05 INBX Buy 57,549 17.56 1,010,560
2024-05-31 INBX Buy 70,193 16.14 1,132,915
2024-06-03 INBX Buy 127,530 17.25 2,200,530
2024-06-04 INBX Buy 89,063 17.84 1,588,883

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kayyem Jon Faiz (Director of Inhibrx Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.